(International Partnership for Microbicides (IPM)) IPM announced today that the New England Journal of Medicine has published results from the Ring Study, a Phase III clinical trial of IPM's vaginal ring to prevent HIV. Also see NEJM's short video summary. The study's key findings, announced earlier this year, show that a vaginal ring that slowly releases the antiretroviral drug (ARV) dapivirine over the course of one month safely helps reduce the risk of HIV infection in women.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2gCNAf3
No comments:
Post a Comment